[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338325-105":59,"doc-detail-338325-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","autophagy-is-required-for-mammary-tumor-recurrence-by-promoting-dormant-tumor-cell-survival-following-therapy","Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy","","Breast cancer mortality is driven largely by tumor recurrence arising from residual cancer cells (minimal residual disease) that can persist in a dormant, quiescent state for decades after initial treatment. The mechanisms supporting dormant tumor cell survival remain unclear, and autophagy has been reported with conflicting pro-survival or pro-death effects. This study resolves autophagy’s role in dormant residual cell survival and therapy-associated recurrence using genetically engineered mouse models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/autophagy-is-required-for-mammary-tumor-recurrence-by-promoting-dormant-tumor-cell-survival-following-therapy/338325/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/autophagy-is-required-for-mammary-tumor-recurrence-by-promoting-dormant-tumor-cell-survival-following-therapy/338325.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is understanding dormant tumor cell survival important in breast cancer research?","Question",{"text":112,"@type":113},"Breast cancer recurrence often develops from minimal residual disease that survives therapy and can remain dormant for 20 years or more. Since recurrent breast cancer is typically incurable, clarifying dormant tumor cell mechanisms is clinically critical.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study test whether autophagy controls dormant tumor cell survival and recurrence?",{"text":117,"@type":113},"The study used genetically engineered mouse models and inhibited autophagy via chloroquine treatment, genetic knockdown of ATG5 or ATG7, or deletion of BECN. Effects on dormant tumor cell survival and recurrence were then assessed.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about autophagy during dormancy and after HER2 downregulation?",{"text":121,"@type":113},"Dormant mammary tumor cell survival and recurrence after therapy depended on autophagy. Autophagy was induced in vivo following HER2 downregulation and remained activated in dormant residual tumor cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338325,1790485550,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Dwyer et al. Breast Cancer Research (2024) 26:143 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-024-01878-7](https://doi.org/10.1186/s13058-024-01878-7)  \nRESEARCH Open Access  \nAutophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy  \nSamantha Dwyer 1,2, Jason Ruth 1,2, Hans E. Seidel 1,2, Amelie A. Raz 1,2 and Lewis A. Chodosh 1,2,3,4*  \nAbstract  \nBackground Mortality from breast cancer is principally due to tumor recurrence. Recurrent breast cancers arise from the pool of residual tumor cells, termed minimal residual disease, that survive treatment and may exist in a dormant state for 20 years or more following treatment of the primary tumor. As recurrent breast cancer is typically incurable, understanding the mechanisms underlying dormant tumor cell survival is a critical priority in breast cancer research. The importance of this goal is further underscored by emerging evidence suggesting that targeting dormant residual tumor cells in early-stage breast cancer patients may be a means to prevent tumor recurrence and its associated mortality. In this regard, the role of autophagy in dormant tumor cell survival and recurrence remains unresolved, with conflicting reports of both pro-survival/recurrence-promoting and pro-death/recurrence-suppressing effects of autophagy inhibition in dormant tumor cells. Resolving this question has important clinical implications.  \nMethods We used genetically engineered mouse models that faithfully recapitulate key features of human breast cancer progression, including minimal residual disease, tumor dormancy, and recurrence. We used genetic and pharmacological approaches to inhibit autophagy, including treatment with chloroquine, genetic knockdown of ATG5 or ATG7, or deletion of BECN and determined their effects on dormant tumor cell survival and recurrence. Results We demonstrate that the survival and recurrence of dormant mammary tumor cells following therapy is dependent upon autophagy. We find that autophagy is induced in vivo following HER2 downregulation and remains activated in dormant residual tumor cells. Using genetic and pharmacological approaches we show that inhibiting autophagy by chloroquine administration, ATG5 or ATG7 knockdown, or deletion of a single allele of the tumor suppressor Beclin 1 is sufficient to inhibit mammary tumor recurrence, and that autophagy inhibition results in the death of dormant mammary tumor cells in vivo.  \nConclusions Our findings demonstrate a pro-tumorigenic role for autophagy in tumor dormancy and recurrence following therapy, reveal that dormant tumor cells are uniquely reliant upon autophagy for their survival, and indicate that targeting dormant residual tumor cells by inhibiting autophagy impairs tumor recurrence. These studies identify a pharmacological target for a cellular state that is resistant to commonly used anti-neoplastic agents and suggest autophagy inhibition as an approach to reduce dormant minimal residual disease in order to prevent lethal tumor recurrence.  \n*Correspondence:  \nLewis A. Chodosh [chodosh@pennmedicine.upenn.edu](chodosh@pennmedicine.upenn.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not incl","cbCaidfvuwoEVFFM","https://ap.wps.com/l/cbCaidfvuwoEVFFM","pdf",3383320,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why is understanding dormant tumor cell survival important in breast cancer research?\",\"answer\":\"Breast cancer recurrence often develops from minimal residual disease that survives therapy and can remain dormant for 20 years or more. Since recurrent breast cancer is typically incurable, clarifying dormant tumor cell mechanisms is clinically critical.\"},{\"question\":\"How did the study test whether autophagy controls dormant tumor cell survival and recurrence?\",\"answer\":\"The study used genetically engineered mouse models and inhibited autophagy via chloroquine treatment, genetic knockdown of ATG5 or ATG7, or deletion of BECN. Effects on dormant tumor cell survival and recurrence were then assessed.\"},{\"question\":\"What did the results show about autophagy during dormancy and after HER2 downregulation?\",\"answer\":\"Dormant mammary tumor cell survival and recurrence after therapy depended on autophagy. Autophagy was induced in vivo following HER2 downregulation and remained activated in dormant residual tumor cells.\"}]","Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy | PDF",1790023077,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1c0b0857025fbff709644467c82b9b5.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cec250a80b61b81979d6ed5551bb9a5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce94de0ef6373405bf118ef9c7b088f3.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72bc106d1dad77e3a02cf79a4d9d749f.webp",980,1306]